4Muller DJ, Kennedy JL. Genetics of antipsychotic treatment emergent weight gain in schizophrenia [ J ]. Summary Pharmacogenomics, 2006,7 : 863-887.
5Tavlor DM, McAskill R. Atypical antipsychotics and weight gain-a systematic review [J].Acta Psychiatr Scand, 2000, 101:416-432.
6Citrome LL, Jaffe AB . Relationship of atypical antipsychotics with Development of diabetes mellitus [ J ]. Annals of Pharmacotherapy, 2003,37 : 1849-1857.
7Farver D. Weight gain and longterm complications with atypical Antipsychotics [ J ]. S D J Med,2001,54 : 11-12.
8Wetterling T. Bodyweight gain with atypical antipsychotics. A comparative review [ J ]. Drug Saf ,2001,24:59-73.
9Weiden PJ, Maekell JA, McDonnell DD. Obesity as a risk factor forantipsychoticnoncompliance [ J ]. Schizophrenia Research,2004, 66:51-57.
10Melkersson Kristina, Dahl, Marja-Liisa. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications [ J]. Drugs ,2004,64:701-723.
